Global Interventional Cardiology Devices Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Interventional cardiology devices are medical devices that are designed to deal with catheter-based approaches to cure structural heart diseases or disorders. The increasing incidences of coronary artery disease, the presence of favorable reimbursements for interventional cardiology procedures, and the increasing prevalence of diabetes and obesity are acting as catalyzing factors for global market growth.

According to the Centers for Disease Control and Prevention, heart disease accounts for the leading cause of death for women, men, and people of most racial and ethnic groups across the US. Coronary heart disease is the most common variety of heart disease that are recorded for the deaths of approximately 382,820 people in 2020, in which nearly 2 in 10 deaths occur because of CAD in adults less than 65 years old. Therefore, the rising frequency of deaths and high cases due to heart disease is presenting various growth prospects to the market around the world. In addition, the development of healthcare facilities in emerging economies, as well as the rising number of product approvals are creating lucrative opportunities for the market in the foreseen years. However, lack of awareness about posture corrector products and high costs related to the R&D activities are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Interventional Cardiology Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the availability of reimbursement, as well as the presence of well-established market players. Whereas, the Asia Pacific is expected to grow significantly during the forecast period. Factors such as rising government investment in healthcare, growing aging population, and increasing prevalence of diabetes are burgeoning the market growth in the forecasting years.

Major market players included in this report are:

Abbott Laboratories

Medtronic

Boston Scientific

Spectranetics

Cardinal Health

Philips Healthcare

Terumo

Alvimedica

Teleflex Medical

B. Braun

Recent Developments in the Market:

In 2020, Edward Lifesciences Corporation has received the Chinese government approval for the company's SAPIEN 3 Transcatheter Heart Valve to treat patients that were suffering from severe, symptomatic aortic stenosis (AS) unable to undergo open-heart surgery.
In 2019, Medtronic announced that its Next-Generation Evolut PRO+ TAVR System has received the US FDA approval. The product is designed for the treatment of symptomatic severe aortic stenosis in patients
In 2019, Abbott declared that for its MitraClip Heart Valve Repair Device has received US FDA approval, which is designed to treat mitral regurgitation.
Global Interventional Cardiology Devices Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Product, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Angioplasty Balloons

Angioplasty Stents

Catheters

Plaque Modification Devices

Hemodynamic Flow Alteration Devices

Other Devices

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World